Company profile for LakeShore Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lakeshore Biotech is dedicated to advancing biomedical innovation with cutting-edge research and development. Specializing in cell therapy, regenerative medicine, and molecular diagnostics, we strive to create impactful solutions for unmet medical needs. Our team of experts is committed to driving scientific progress and improving patient outcomes through collaboration and advanced technologies. Guided by excellence and a visi...
Lakeshore Biotech is dedicated to advancing biomedical innovation with cutting-edge research and development. Specializing in cell therapy, regenerative medicine, and molecular diagnostics, we strive to create impactful solutions for unmet medical needs. Our team of experts is committed to driving scientific progress and improving patient outcomes through collaboration and advanced technologies. Guided by excellence and a vision for a healthier future, Lakeshore Biotech continues to innovate for the betterment of global health.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Hong Kong
Address
Address
Oom 32, 11/f, Lee Ka Industrial Building, 8 Ng Fong Street, San Po Kong
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/lakeshore-biopharma-enters-into-definitive-agreement-for-going-private-transaction-302603988.html

PR NEWSWIRE
04 Nov 2025

https://www.prnewswire.com/news-releases/lakeshore-biopharma-announces-transition-to-otc-market-following-nasdaq-delisting-302562861.html

PR NEWSWIRE
22 Sep 2025

https://www.prnewswire.com/news-releases/lakeshore-biopharma-announces-receipt-of-delisting-determination-letter-from-nasdaq-302555072.html

PR NEWSWIRE
12 Sep 2025

https://www.prnewswire.com/news-releases/lakeshore-biopharma-announces-appointment-of-independent-financial-advisor-and-legal-counsel-to-the-special-committee-302552480.html

PR NEWSWIRE
10 Sep 2025

https://www.prnewswire.com/news-releases/lakeshore-biopharma-announces-receipt-of-a-revised-preliminary-non-binding-proposal-to-acquire-the-company-and-formation-of-special-committee-302541021.html

PR NEWSWIRE
28 Aug 2025

https://www.prnewswire.com/news-releases/lakeshore-biopharma-announces-receipt-of-a-preliminary-non-binding-proposal-to-acquire-the-company-302532192.html

PR NEWSWIRE
18 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty